Related references
Note: Only part of the references are listed.The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma
Jiao Li et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Sulfated polysaccharide of Sepiella Maindroni ink inhibits the migration, invasion and matrix metalloproteinase-2 expression through suppressing EGFR-mediated p38/MAPK and PI3K/Akt/mTOR signaling pathways in SKOV-3 cells
Wenjie Jiang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression
Li-Li Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells
Te-Chih Cheng et al.
MARINE DRUGS (2017)
Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer
Zhonghua Ma et al.
MOLECULAR BIOSYSTEMS (2017)
Dysregulated expression of long noncoding RNAs in gynecologic cancers
Elahe Seyed Hosseini et al.
MOLECULAR CANCER (2017)
Downregulation of TM7SF4 inhibits cell proliferation and metastasis of A549 cells through regulating the PI3K/AKT/mTOR signaling pathway
Xudong Yang et al.
MOLECULAR MEDICINE REPORTS (2017)
Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway
Hong Jin et al.
MOLECULAR MEDICINE REPORTS (2017)
Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors
Vanessa F. Merino et al.
MOLECULAR ONCOLOGY (2017)
Fibroblast-derived CXCL12/SDF-1α promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K/Akt/mTOR pathway in colon cancer
Jia-Chi Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
被撤回的出版物: Globularifolin exerts anticancer effects on glioma U87 cells through inhibition of Akt/mTOR and MEK/ERK signaling pathways in vitro and inhibits tumor growth in vivo (Retracted article. See vol. 204, pg. 170, 2023)
Yunhu Yu et al.
BIOCHIMIE (2017)
'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling
Mei S. Ong et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Long Noncoding RNA and Cancer: A New Paradigm
Arunoday Bhan et al.
CANCER RESEARCH (2017)
Cytogenetic Analysis of a Pseudoangiomatous Pleomorphic/Spindle Cell Lipoma
Ioannis Panagopoulos et al.
ANTICANCER RESEARCH (2017)
Cancer Screening in the United States, 2017: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening
Robert A. Smith et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer
Kaijiong Zhang et al.
CANCER BIOMARKERS (2016)
The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer
Hee Jung Kim et al.
ONCOTARGET (2016)
Monoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K)
Beata Grygalewicz et al.
MOLECULAR CYTOGENETICS (2016)
Microarray expression profile of lncRNAs and the upregulated ASLNC04080 lncRNA in human endoMetrial carcinoma
Wen Zhai et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Analysis of the miRNA-mRNA-lncRNA networks in ER plus and ER- breast cancer cell lines
Qian Wu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Molecular Alterations of PIK3CA in Uterine Carcinosarcoma, Clear Cell, and Serous Tumors
Shazia Bashir et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
Jiri Polivka et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer
Athanasia Pavlidou et al.
SCIENTIFIC WORLD JOURNAL (2014)
The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
Brian M. Slomovitz et al.
CLINICAL CANCER RESEARCH (2012)
Emerging therapeutic targets in endometrial cancer
Konstantin J. Dedes et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Share Paper
